Clinical analysis of the combination regimen with Bcl-2 inhibitor venetoclax in the treatment of 30 cases of acute myeloid leukemia with IDH1/2 mutation

Saved in:

Bibliographic Details
Published in:	Zhōnghuá xuèyèxué zázhì Vol. 43; no. 8; pp. 691 - 694
Main Authors:	Wang, X, Bao, X B, Zhang, J, Song, B Q, Li, M Y, Xie, J D, Shen, H J, Wu, D P, Qiu, H Y
Format:	Journal Article
Language:	Chinese
Published:	China 14-08-2022
Subjects:	Antineoplastic Agents - therapeutic use Bridged Bicyclo Compounds, Heterocyclic - pharmacology Bridged Bicyclo Compounds, Heterocyclic - therapeutic use Humans Isocitrate Dehydrogenase - genetics Isocitrate Dehydrogenase - therapeutic use Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - genetics Mutation Proto-Oncogene Proteins c-bcl-2 - genetics
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0253-2727
DOI:	10.3760/cma.j.issn.0253-2727.2022.08.014